PROFESSIONAL EDITION

The largest community of pharma leaders

Newsletters

Exicure Granted Orphan Drug Designation by the U.S. Food and Drug Administration for Cavrotolimod

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced...

Quantum Materials Corp Expands Executive Leadership Team To Execute Growth Strategy

SAN MARCOS, Texas--(BUSINESS WIRE)--Quantum Materials Corp (QMC), today announced that it has recently appointed three members to executive leadership: Senior Vice President Clinical R&D...

Recent Articles